Enlivex Ltd ENLV

$1.05 -0.12 (-10.26%)

Valuation

Market cap
1,609,000
Revenue TTM
$0
Net income TTM
$1,235,530,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
40,900
Avg volume
88,718
Day's range
$1.05 – $1.22
Shares out
1,532,000
Stochastic %K
14%
Beta
1.63
Analysts
Moderate Buy
Price target
$1,280.00

Price

Company profile

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint...

Show more

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 2 620 8072
Website
https://www.enlivex.com
Address
14 Einstein Street, Ness Ziona, Israel

Latest news

Stocktwits

GridironGainz Nov 19, 9:06 PM 0 replies
Danson4 Nov 18, 5:08 PM
$ENLV Check out the SEC 6-K listings in the last few days ! Positive review of trial daya and $7.X mil in funding to get them through ubtil trial end. Some good news finally !
1 replies
focafoca99 Nov 18, 1:14 PM
$ENLV disclosed an interim safety review of its Phase IIb Allocetra knee osteoarthritis trial, covering 85 patients.
0 replies
ReversalRuler Nov 13, 7:05 PM
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $ENLV $TWG $SXTC $SBFM ++
0 replies
ReversalRuler Nov 12, 6:26 PM 0 replies
Trade4Keeps Nov 9, 11:08 PM
$ENLV this hit 10 days over a dollar today. We'll see if NASDAQ grants compliance.
0 replies
JJRADANO Nov 9, 3:22 PM
$ENLV I hope the sleezebags are selling their tokens. It looks so. We need the cash to see Allocetra to the finish line.
0 replies
mikethemage Nov 5, 3:40 PM
$ENLV oh scam
0 replies